HealthcareServices

Peripheral Nerve Stimulators Industry Anticipated to Expand at 8.4% CAGR During the Forecast Period

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Peripheral Nerve Stimulators Market Between 2025 And 2029?

The peripheral nerve stimulators market has observed robust growth in recent years. This market is forecasted to increase from $0.7 billion in 2024 to $0.76 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.2%. The expansion seen in the historical period is primarily linked to the rising demand for non-pharmacological pain management solutions, increased public awareness regarding alternative therapies for pain relief, a greater adoption of minimally invasive surgical techniques, an expanding elderly demographic, and an increasing proliferation of pain management clinics.

The peripheral nerve stimulators market is projected to experience substantial expansion over the upcoming years. This sector is anticipated to reach $1.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected increase is fueled by factors such as supportive government policies and programs, an increasing inclination towards outpatient and home-based care options, the proliferation of pain management clinics, a heightened need for tailored PNS devices, and the continuous development of healthcare infrastructure. Significant evolving trends within this period encompass the creation of wireless peripheral nerve stimulators, the incorporation of mobile applications for remotely overseeing PNS devices, the launch of wearable, non-invasive PNS solutions, and the emergence of sophisticated PNS systems featuring AI-driven pain management capabilities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20923&type=smp

Which Drivers Are Shaping The Peripheral Nerve Stimulators Industry’s Market Share?

The rising incidence of neurological conditions is anticipated to drive expansion within the peripheral nerve stimulators market. These conditions refer to medical ailments impacting the brain, spinal cord, or peripheral nerves, resulting in functional, structural, or biochemical irregularities. The widespread occurrence of neurological disorders stems from elements like an aging demographic, genetic susceptibilities, environmental factors, lifestyle decisions, and improved understanding and detection of these conditions. Peripheral nerve stimulators are vital in mitigating the impact of neurological disorders by offering focused alleviation of chronic pain, improving motor capabilities, and fostering nerve regrowth in compromised regions. For example, data from March 2023, provided by the Alzheimer’s Association, a US-based nonprofit voluntary health organization, indicated that in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia, a figure expected to escalate to 13.8 million by 2060. Consequently, the growing prevalence of neurological conditions is fueling the expansion of peripheral nerve stimulators.

What Are The Key Segments In The Peripheral Nerve Stimulators Market?

The peripheral nerve stimulatorsmarket covered in this report is segmented –

1) By Product: Transcutaneous; Percutaneous; Implantable

2) By Device: Stimulators; CPNB Catheters; Pain Pumps; Other Devices

3) By Mode of Purchase: Disposable Devices; Rechargeable Devices

4) By Application: Hospitals; Physiotherapy Centers; Ambulatory Surgical Centers; Clinics; Other Applications

Subsegments:

1) By Transcutaneous: TENS (Transcutaneous Electrical Nerve Stimulation) Units; Surface Electrodes

2) By Percutaneous: Single-Needle Percutaneous Stimulators; Multi-Needle Percutaneous Stimulators; Radiofrequency Percutaneous Stimulators

3) By Implantable: Spinal Cord Stimulators (SCS); Peripheral Nerve Stimulation (PNS) Devices; Neurostimulator Implants

Which Market Trends Are Creating New Opportunities In The Peripheral Nerve Stimulators Industry?

Leading companies operating within the peripheral nerve stimulators market are prioritizing the creation of innovative products, including ultra-miniaturized systems, with the goal of elevating patient comfort, refining treatment outcomes, and extending applications into diverse therapeutic areas. Ultra-miniaturized systems are characterized as exceptionally compact and small-scale devices designed for sophisticated functionalities, often leveraging cutting-edge technologies to augment their performance, portability, and seamless integration across various uses. As an illustration, in April 2023, NeuSpera Medical Inc., a US-based manufacturer of implantable medical devices, declared that it had received U.S. Food and Drug Administration (FDA) clearance for its subsequent generation Neuspera ultra-miniaturized system, designated for chronic peripheral nerve pain management. This particular device is distinctively engineered to deliver precise electrical impulses to peripheral nerves without the necessity of traditional leads, rendering it minimally invasive and mitigating the risk of complications typically associated with lead-based devices. Its compact dimensions allow for effortless implantation with less disturbance to tissues, thus promoting faster recuperation times. The micro-implant also holds the promise of long-term pain relief by directly stimulating the affected nerve pathways, offering an advanced remedy for patients afflicted with chronic peripheral nerve pain.

Who Are The Primary Competitors In The Global Peripheral Nerve Stimulators Market?

Major companies operating in the peripheral nerve stimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Globus Medical Inc., Livanova plc, Nevro Corp., Axonics Modulation Technologies, Saluda Medical Pty Ltd., Stimwave Technologies Incorporated, Nalu Medical Inc., Bioness Inc., SPR Therapeutics Inc., Neuspera Medical Inc., B. Braun Melsungen AG, NeuroMetrix Inc., BioElectronics Corporation, Soterix Medical Inc., Xavant Technology Pty Ltd., Neurostimulation Technologies, STIM Systems

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/peripheral-nerve-stimulators-global-market-report

How Is Peripheral Nerve Stimulators Market Demand Varying Across Different Regions?

North America was the largest region in the peripheral nerve stimulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral nerve stimulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Peripheral Nerve Stimulators Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20923&type=smp

Browse Through More Reports Similar to the Global Peripheral Nerve Stimulators Market 2025, By The Business Research Company

Peripheral Iv Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Computer And Peripherals Support Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-and-peripherals-support-services-global-market-report

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795